Helix Acquisition II’s quiet period is set to end March 20. The SPAC last month issued 16 million shares in its IPO at $10 a share. The final raise came to $184 million with the full exercise of the iunderwriters’ over-allotment option.
During the SPAC’s quiet period, underwriters and any insiders are restricted from issuing research reports for the company due to SEC regulations. Following the end of the quiet period, it’s expected the brokerages that served as underwriters will initiate research coverage on Helix II.
Formed by Cormorant Asset Management, Helix II intends to focus on the healthcare industry. Read more.
